Jacobs Levy Equity Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
FLAM
RSCM
PAMP
Jacobs Levy Equity Management's XENT Position: Q2 2021 in Review
Jacobs Levy Equity Management sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 274,271 shares — an estimated $5.73M sold.
Jacobs Levy Equity Management first reported a position in XENT in Q4 2016 and held it in 15 quarters. The position peaked at $6.01M in Q4 2020. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.
- Jacobs Levy Equity Management reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
- Jacobs Levy Equity Management sold 274,271 Intersect ENT, Inc shares in Q2 2021, an estimated $5.73M.
- Jacobs Levy Equity Management first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 15 quarters.
- Jacobs Levy Equity Management's Intersect ENT, Inc position peaked at $6.01M in Q4 2020.
- 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.